A new analysis suggests that finerenone (Kerendia), a newer heart failure medication, may help older adults rely less on high doses of water pills. The findings come from the large FINEARTS-HF ...

Pennington Biomedical Research Center researchers at the Metamor Institute, along with colleagues from Our Lady of the Lake and LSU Health-New Orleans, have recently determined that metabolic surgery ...

An informal, nonsanctioned meta-analysis of 10 recent clinical trials in heart failure [1] has confirmed the importance of ALLHAT (the Antihypertensive and Lipid-Lowering treatment to prevent Heart ...

CHICAGO -- A bumetanide nasal spray in development for heart failure was well-tolerated and showed reliable rates of absorption compared with oral and intravenous delivery in a phase I trial of ...

Aims Loop diuretics are recommended to treat congestion in heart failure (HF), despite limited quality evidence. High-dose (HD) loop diuretics seem to worsen outcomes in chronic HF, though; data for ...

Panelists discuss how β-blockers remain foundational therapy for heart failure with reduced ejection fraction (using evidence-based agents like carvedilol, metoprolol succinate, or bisoprolol) with ...

This news release contains updated information from the researcher that was not in the abstract. CHICAGO, Nov. 18, 2024 — A new nasal spray form of the medication bumetanide may reduce the tissue ...

The SGLT2 inhibitor medicines have changed how heart failure is managed. Originally sodium-glucose cotransporter 2 (SGLT2) inhibitors were used to lower blood sugar levels in people who have type 2 ...

Death risk doubled for patients experiencing early hyponatremia after starting a thiazide diuretic. Patients who experience hyponatremia soon after starting thiazide diuretics have an increased risk ...